NHI approves first patient for NT$49 million muscle atrophy drug
Taipei, Aug. 21 (CNA) Taiwan’s National Health Insurance (NHI) system has approved its first-ever patient to receive a one-time NT$49 million (US$1.53 million) drug for spinal muscular atrophy (SMA), which was added to a list of covered treatments earlier this month, an official said Monday.